NCT07216573View on ClinicalTrials.gov

The Continuity Study

NANot yet recruitingINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Blood Pressure
Interventions
DEVICE

HemoSphere Vita Monitor, VitaWave or VitaWave Plus Finger Cuff Adult, ForeSight Large Sensors

Devices are applied for monitoring throughout the duration of the procedure.

Trial Locations (1)

14620

University of Rochester Medical Center, Rochester

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY